2018 Pan Pacific Lymphoma Conference

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

2018 Pan Pacific Lymphoma Conference

Bench to Bedside
Novel Therapies in Lymphoma
High Grade B-cell Lymphoma
Aggressive T-Cell Lymphoma
Hodgkin Lymphoma
Multiple Myeloma/Plasma Cell Dyscrasia
Common Indolent Lymphoma
Uncommon Indolent Lymphoma
Interprofessional Educational Day

Playback speed

10 seconds

The Tumor Microenvironment: A Rational Therapeutic Target in Indolent B-cell Malignancies

By 2018 Pan Pacific Lymphoma Conference FEATURING John Gribben

120 views

August 23, 2018

Comments 0

Making the First Chance Count: Manuel

Feat. A. Ip

New Approval for Frontline Consolidation in Patients with CD19-posit…

Feat. J. Mccloskey

Common Indolent Lymphoma

The Tumor Microenvironment: A Rational Therapeutic Target in Indolen…

2018 Pan Pacific Lymphoma Conference

J. Gribben

120 views

The Tumor Microenvironment Using Immune Checkpoint Inhibitors

2018 Pan Pacific Lymphoma Conference

J. Gribben

491 views

CLL: How to Sequence Therapy Options (Frontline)

2018 Pan Pacific Lymphoma Conference

S. O'Brien

226 views

CLL: How to Sequence Therapy Options (Relapse)

2018 Pan Pacific Lymphoma Conference

S. O'Brien

880 views

Evolution of Treatment in Mantle Cell Lymphoma: Clinical Trials vs. …

2018 Pan Pacific Lymphoma Conference

A. Goy

128 views

Mantle Cell Lymphoma: Strategies to Prevent/Delay Relapse

2018 Pan Pacific Lymphoma Conference

A. Goy

269 views

Novel Combinations in Follicular Lymphoma in 2018

2018 Pan Pacific Lymphoma Conference

J. Friedberg

81 views

Mutiple Facets of Marginal Zone Lymphoma: Diagnosis and Classificati…

2018 Pan Pacific Lymphoma Conference

E. Zucca

93 views